Penserra Capital Management LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1593324
ORINDA, CA
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$195,796
-$85,450 QoQ
Shares Held
323
-13.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,054
of 1,322 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $16,002,475 across 25 Biotechnology names. REGN ranks #13 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
54,216 | $3,080,010 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
11,268 | $2,758,068 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
50,017 | $2,747,933 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
5,142 | $1,911,127 | |
| 5 | BCAX |
Bicara Therapeutics Inc.
|
31,066 | $922,349 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
16,660 | $845,495 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
6,300 | $836,199 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
26,929 | $830,221 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $195,796 | 323 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $281,246 | 373 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $188,342 | 253 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $202,416 | 360 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $206,329 | 402 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $5 | 9 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $196,602 | 276 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9 | 9 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $9 | 9 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,662 | 9 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $427,734 | 496 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $521,755 | 634 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $534,592 | 744 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $41,087 | 56 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $40,402 | 56 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $70,264 | 102 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,458 | 16 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,923,998 | 8,482 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,325,256 | 3,682 | Shares | Defined | 2022-02-15 | |
| 2020-06-30 | $1,053,968 | 1,690 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,900,514 | 14,132 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||